Fusion Biopsy Market - Global Industry Analysis

The global Fusion Biopsy Market accrued earnings worth approximately 479 (USD Million) in 2020 and is predicted to gain revenue of about 955 (USD Million) by 2028, is set to record a CAGR of nearly 11.7% over the period from 2021 to 2028. The report offers assessment and analysis of the Fusion Biopsy Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million).

Fusion Biopsy Market: Overview

Fusion biopsy is a method that combines images taken by MRI Scan machine & ultrasound for producing comprehensive image of prostrate. Moreover, the procedure makes it easy to observe enlarged abnormal tissues and thus helps in guiding biopsy needle into the tissues with abnormal enlargement. Furthermore, with help of fusion biopsy, a sample of cell tissues can be extracted from enlarged abnormal tissues and monitored under electron microscope for diagnosing symptoms of cancer. In addition to this, fusion biopsy can detect cancer cell tissues in prostrate that other biopsies can probably miss out. Reportedly, it assists physicians in identification of cancer at initial phase, thereby planning early treatment of the chronic disorder.

Fusion Biopsy Market: Growth Drivers

A prominent surge in incidences of prostate cancer has resulted into massive demand for fusion biopsy in recent years. In addition to this, fusion biopsy has ability to localize dominant ailment and accurately classify disease risk. Furthermore, it can rectify drawbacks of systematic biopsies and avoid biopsy of subjects having normal MRI, thereby restricting over detection of indolent lumps.  Apart from this, fusion biopsy assist in targeting candidates with MRI identifying abnormalities, get less false negative reports leading to reduction in number of repeated biopsies, and derive accurate classification of prostate cancer. All these aforementioned aspects will steer growth of fusion biopsy industry over years ahead.

Moreover, growing significance of routine medical interventions has resulted in massive penetration of fusion biopsy in healthcare sector, thereby driving market trends. Apparently, favorable compensation policies pertaining to use of fusion biopsy for detecting prostate cancer will result in massive market demand.

Report Scope:

Regional Landscape

Asia Pacific Fusion Biopsy Market To Register Highest CAGR of Nearly 12.1 Over 2021-2028

Growth of fusion biopsy market in Asia Pacific over forecast timeline can be attributed to surge in awareness about prostate cancer among population of region. In addition to this, unhealthy food habits as well as unstructured, undisciplined & inconsistent lifestyle of people in region has further contributed to chronic disorders such as prostate cancer resulting in rise in use of fusion biopsy in healthcare sector. Undoubtedly, a rapid increase in geriatric population susceptible to various kinds of prostrate problems will enlarge scope of fusion biopsy industry in sub-continent. Unmet medical needs of patients in countries such as China, India, and Japan will create new growth avenues for fusion biopsy market in Asia Pacific.

Competitive Landscape

Our report includes some of the key industry players that have strongly influenced business landscape. They are MedCom, Focal Healthcare, ESAOTE SPA, GeoScan Medical, KOELIS, and UC-Care Medical Systems Limited.

The global Fusion Biopsy Market is segmented as follows:

By Biopsy Route

• Transrectal
• Transperineal

By End-Use

• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodulogy
    • 1.3.1. Market Research Type
    • 1.3.2. Market Research Methodulogy
• Chapter 2. Executive Summary
  • 2.1. Fusion Biopsy Market, 2018–2028(USD Million)
  • 2.2. Fusion Biopsy Market: Snapshot
• Chapter 3. Global Fusion Biopsy Market– Industry Analysis
  • 3.1. Fusion Biopsy Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Favorable compensation guidelines related to utilization of fusion biopsy for detecting prostate cancer tissues will culminate into humungous market demand.
    • 3.2.2. Escalating significance of routine medical interventions has prompted huge penetration of fusion biopsy in healthcare sector, thereby driving business trends.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Application
    • 3.4.2. Market attractiveness analysis By End-Use
• Chapter 4. Global Fusion Biopsy Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Fusion Biopsy Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Service launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Fusion Biopsy Market– Biopsy Route Analysis
  • 5.1. Global Fusion Biopsy Market overview: By Biopsy Route
    • 5.1.1. Global Fusion Biopsy Market share, By Biopsy Route, 2020 and 2028
  • 5.2. Transrectal
    • 5.2.1. Global Fusion Biopsy Marketby Transrectal, 2018–2028(USD Million)
  • 5.3. Transperineal
    • 5.3.1. Global Fusion Biopsy Market by Transperineal, 2018–2028(USD Million)
• Chapter 6. Global Fusion Biopsy Marketoverview: By End-Use
  • 6.1. Global Fusion Biopsy Marketshare, By End-Use, 2020 and 2028
  • 6.2. Hospitals
    • 6.2.1. Global Fusion Biopsy Marketby Hospitals , 2018–2028(USD Million)
  • 6.3. Diagnostic Centers
    • 6.3.1. Global Fusion Biopsy Marketby Diagnostic Centers, 2018–2028(USD Million)
  • 6.4. Ambulatory Care Centers
    • 6.4.1. Global Fusion Biopsy Marketby Ambulatory Care Centers, 2018–2028(USD Million)
• Chapter 7. Company Profiles
  • 7.1. MedCom
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Service Portfulio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Focal Healthcare
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Service Portfulio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. ESAOTE SPA
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Service Portfulio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Development
  • 7.4. GeoScan Medical
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Service Portfulio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Development
  • 7.5. KOELIS
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Service Portfulio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. UC-Care Medical Systems Limited
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Service Portfulio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Fusion Biopsy Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Fusion Biopsy Marketattractiveness, By Biopsy Route
6. Global Fusion Biopsy Marketattractiveness, By End-Use
7. Global Fusion Biopsy Marketshare by Biopsy Route ,2020 and 2028 (USD Million)
8. Global Fusion Biopsy Marketby Transrectal, 2018–2028(USD Million)
9. Global Fusion Biopsy Marketby Transperineal, 2018–2028(USD Million)
10. Global Fusion Biopsy Marketshare by End-Use,2020 and 2028 (USD Million)
11. Global Fusion Biopsy Marketby Hospitals,  2018–2028(USD Million)
12. Global Fusion Biopsy Marketby Diagnostic Centers, 2018–2028(USD Million)
13. Global Fusion Biopsy Marketby Ambulatory Care Centers, 2018–2028(USD Million)
14. Global Fusion Biopsy Marketshare, by Region, 2020 and 2028
15. North America Fusion Biopsy Market, 2018–2028(USD Million)
16. Europe Fusion Biopsy Market, 2018–2028(USD Million)
17. Asia Pacific Fusion Biopsy Market, 2018–2028(USD Million)
18. Latin America Fusion Biopsy Market, 2018–2028(USD Million)
19. The Middle East and Africa Fusion Biopsy Market, 2018–2028(USD Million)

Table Of Tables

List of Tables

1. Global Fusion Biopsy Market: snapshot
2. Drivers of the Fusion Biopsy Market: impact analysis
3. North America Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
4. North America Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
5. The U.S. Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
6. The U.S. Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
7. Rest of North America Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
8. Rest of North America Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
9. Europe Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
10. Europe Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
11. UK Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
12. UK Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
13. France Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
14. France Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
15. Germany Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
16. Germany Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
17. Rest of Europe Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
18. Rest of Europe Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
19. Asia Pacific Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
20. Asia Pacific Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
21. China Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
22. China Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
23. Japan Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
24. Japan Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
25. India Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
26. India Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
27. Rest of Asia Pacific Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
28. Rest of Asia Pacific Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
29. Latin America Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
30. Latin America Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
31. Brazil Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
32. Brazil Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
33. Rest of Latin America Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
34. Rest of Latin  America Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
35. The Middle East and Africa Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
36. The Middle East and Africa Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
37. Saudi Arabia Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
38. Saudi Arabia Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
39. South Africa Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
40. South Africa Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)
41. Rest of the Middle East & Africa Fusion Biopsy Marketrevenue, By Biopsy Route  ,2018–2028(USD Million)
42. Rest of the Middle East & Africa Fusion Biopsy Marketrevenue, By End-Use,2018–2028(USD Million)